These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles. Lavie I; Rao GG; Castrillon DH; Miller DS; Schorge JO Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109 [TBL] [Abstract][Full Text] [Related]
27. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy. Ngan HY; Wong LC Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563 [TBL] [Abstract][Full Text] [Related]
28. Transient hyperthyroidism in an adolescent with hydatidiform mole. Misra M; Levitsky LL; Lee MM J Pediatr; 2002 Mar; 140(3):362-6. PubMed ID: 11953736 [No Abstract] [Full Text] [Related]
29. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585 [TBL] [Abstract][Full Text] [Related]
30. Hydatidiform mole. A follow-up regimen for identification of invasive mole and choriocarcinoma and for selection of patients for treatment. Brewer JI; Torok EE; Webster A; Dolkart RE Am J Obstet Gynecol; 1968 Jun; 101(4):557-63. PubMed ID: 5690298 [No Abstract] [Full Text] [Related]
31. [Serum TSH levels in normal pregnant women and patients with hydatidiform mole and influence of HCG on TSH immunoradiometric assay]. Hara H; Ban Y; Sato R; Nagakura H; Kushima K; Kaihara M; Matsuzaki H Kaku Igaku; 1988 Jan; 25(1):89-96. PubMed ID: 3373811 [No Abstract] [Full Text] [Related]
32. Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma. Teoh ES; Das NP; Dawood MY; Ratnam SS Acta Endocrinol (Copenh); 1972 Aug; 70(4):791-800. PubMed ID: 5068403 [No Abstract] [Full Text] [Related]
33. Nausea and vomiting of pregnancy: role of human chorionic gonadotropin and 17-hydroxyprogesterone. Soules MR; Hughes CL; Garcia JA; Livengood CH; Prystowsky MR; Alexander E Obstet Gynecol; 1980 Jun; 55(6):696-700. PubMed ID: 7383455 [TBL] [Abstract][Full Text] [Related]
34. An unusual clinical course after mole evacuation: a case report. Okamoto T; Nakanishi T; Nomura S; Goto S; Sakaida H; Tomoda Y Nagoya J Med Sci; 1997 Mar; 60(1-2):49-52. PubMed ID: 9212649 [TBL] [Abstract][Full Text] [Related]
35. [Application of a rapid HCG-RIA technique in clinical obstetric and gynecology practice (author's transl)]. Xu RQ Zhonghua Fu Chan Ke Za Zhi; 1981 Jan; 16(1):29-32. PubMed ID: 7297230 [No Abstract] [Full Text] [Related]
37. Human chorionic gonadotropin and thyroid function in patients with hydatidiform mole. Amir SM; Osathanondh R; Berkowitz RS; Goldstein DP Am J Obstet Gynecol; 1984 Nov; 150(6):723-8. PubMed ID: 6496594 [TBL] [Abstract][Full Text] [Related]
38. Follow-up of gestational trophoblastic disease by thyrotropin-releasing hormone test: a case study. Miyamoto J Keio J Med; 1985 Sep; 34(3):161-6. PubMed ID: 3936962 [No Abstract] [Full Text] [Related]
39. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands. Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723 [TBL] [Abstract][Full Text] [Related]
40. Differences in current clinical features of diploid and triploid hydatidiform mole. Niemann I; Petersen LK; Hansen ES; Sunde L BJOG; 2007 Oct; 114(10):1273-7. PubMed ID: 17655732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]